ABT vs JHG · P/E 25, rev $44.33B vs P/E 16, rev $3.10B
Abbott Laboratories (ABT) versus Janus Henderson Group PLC (JHG) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Janus Henderson Group PLC (JHG) is a asset management company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported JHG revenue for 2025-12-31 was $3.10B. Net income was $815.9M. Revenue was up 25.2% from 2024-12-31 to 2025-12-31. JHG currently screens at market cap $6.50B and trailing P/E 16.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. JHG currently screens at market cap $6.50B and trailing P/E 16.4.
Not investment advice. Open the ABT and JHG stock pages for the full models.
Not investment advice.